CRG Amends Omeros Credit Facility
Affiliates of investment firm CRG amended the credit facility for Omeros, a biopharmaceutical company focused on small-molecule and protein therapeutics.
Affiliates of investment firm CRG amended the credit facility for Omeros, a biopharmaceutical company focused on small-molecule and protein therapeutics.
Omeros completed the initial funding under its senior secured credit facility with affiliates of CRG, a healthcare-focused investment firm, consisting of an $80 million term loan.
Omeros entered into a $125 million term loan agreement with CRG Servicing as administrative agent.
Omeros has entered into an amendment to its existing credit facility with Oxford Finance and East West Bank. The banks will provide an additional $20 million in unrestricted cash by funding the remaining tranches of the existing facility.
Omeros Corporation has closed a $70 million non-dilutive senior credit facility with Oxford Finance and East West Bank.